Delay in addressing harassment allegations against Dr. H.C. Lokesh at HIMS leaves staff worried, despite inquiry findings.

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

The bitter irony is that Republican policies in states with high obesity rates only exacerbate the gaps in health outcomes.

The Bombay High Court has quashed an FIR against trustees of the HIMS Botawala Charitable Trust following an amicable ...

Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Hims & Hers (HIMS) is up 14.0%, or $4.29 to $34.97.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...

The Nasdaq and S&P 500 could snap win streaks as investors unpack inflation data and take profits before Thanksgiving ...

Nutrafol is a leader in supplement-based hair loss treatments, offering a natural way to support healthy hair growth. Their ...

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

3. Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg reported Nov. 25. 4. Sesame provides compounded versions of the popular ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.